Beyond triple-negative breast cancer: the need to define new subtypes
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond triple-negative breast cancer: the need to define new subtypes
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 10, Issue 8, Pages 1197-1213
Publisher
Informa UK Limited
Online
2010-08-25
DOI
10.1586/era.10.50
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Final Overall Survival (OS) Results from the Randomised, Double-Blind, Placebo-Controlled, Phase III AVADO Study of Bevacizumab (BV) Plus Docetaxel (D) Compared with Placebo (PL) Plus D for the First-Line Treatment of Locally Recurrent (LR) or Metastatic Breast Cancer (mBC).
- (2010) D. Miles et al. CANCER RESEARCH
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
- (2010) Daniel P. Silver et al. JOURNAL OF CLINICAL ONCOLOGY
- Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas)
- (2010) C. Marchio et al. JOURNAL OF CLINICAL PATHOLOGY
- Breast cancer molecular profiling with single sample predictors: a retrospective analysis
- (2010) Britta Weigelt et al. LANCET ONCOLOGY
- Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
- (2010) N Turner et al. ONCOGENE
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response
- (2009) Jorma J. de Ronde et al. BREAST CANCER RESEARCH AND TREATMENT
- Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers
- (2009) Sharon Nofech-Mozes et al. BREAST CANCER RESEARCH AND TREATMENT
- An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers
- (2009) Rachael Natrajan et al. BREAST CANCER RESEARCH AND TREATMENT
- CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification
- (2009) Pamela Klingbeil et al. BREAST CANCER RESEARCH AND TREATMENT
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
- (2009) Krishna M. Vasudevan et al. CANCER CELL
- High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors
- (2009) E. Manie et al. CANCER RESEARCH
- Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
- (2009) O. K. Mirzoeva et al. CANCER RESEARCH
- Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
- (2009) B. T. Hennessy et al. CANCER RESEARCH
- Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array
- (2009) F. Andre et al. CLINICAL CANCER RESEARCH
- Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
- (2009) R. Natrajan et al. CLINICAL CANCER RESEARCH
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
- (2009) E. A. Rakha et al. CLINICAL CANCER RESEARCH
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication
- (2009) M B K Lambros et al. JOURNAL OF CLINICAL PATHOLOGY
- The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type
- (2009) Britta Weigelt et al. JOURNAL OF PATHOLOGY
- Complex landscapes of somatic rearrangement in human breast cancer genomes
- (2009) Philip J. Stephens et al. NATURE
- Histological and molecular types of breast cancer: is there a unifying taxonomy?
- (2009) Britta Weigelt et al. Nature Reviews Clinical Oncology
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets
- (2009) Elizabeth Iorns et al. PLoS One
- Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
- (2009) E. Caldas-Lopes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial
- (2008) O. Gluz et al. ANNALS OF ONCOLOGY
- Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis
- (2008) Britta Weigelt et al. BREAST CANCER RESEARCH AND TREATMENT
- Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH
- (2008) Simon A. Joosse et al. BREAST CANCER RESEARCH AND TREATMENT
- Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
- (2008) T. Byrski et al. BREAST CANCER RESEARCH AND TREATMENT
- TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
- (2008) Monzur Rahman et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status
- (2008) William D. Foulkes et al. BREAST CANCER RESEARCH AND TREATMENT
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer
- (2008) Nancy U. Lin et al. CANCER
- Molecular Subtypes in Breast Cancer Evaluation and Management: Divide and Conquer
- (2008) Jeffrey Peppercorn et al. CANCER INVESTIGATION
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs
- (2008) Kei-ichi Ozaki et al. CANCER SCIENCE
- RiBBON 1 and RiBBON 2: Phase III Trials of Bevacizumab with Standard Chemotherapy for Metastatic Breast Cancer
- (2008) Joyce A. O'Shaughnessy et al. Clinical Breast Cancer
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
- (2008) C. Desmedt et al. CLINICAL CANCER RESEARCH
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- DNA copy number alterations and expression of relevant genes in triple-negative breast cancer
- (2008) Wonshik Han et al. GENES CHROMOSOMES & CANCER
- How basal are triple-negative breast cancers?
- (2008) François Bertucci et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical and Pathologic Characteristics of Patients WithBRCA-Positive andBRCA-Negative Breast Cancer
- (2008) Deann P. Atchley et al. JOURNAL OF CLINICAL ONCOLOGY
- Basal-Like Breast Cancer: A Critical Review
- (2008) Emad A. Rakha et al. JOURNAL OF CLINICAL ONCOLOGY
- A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair
- (2008) Alan Ashworth JOURNAL OF CLINICAL ONCOLOGY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Nestin is expressed in basal-like and triple negative breast cancers
- (2008) S Parry et al. JOURNAL OF CLINICAL PATHOLOGY
- Refinement of breast cancer classification by molecular characterization of histological special types
- (2008) B Weigelt et al. JOURNAL OF PATHOLOGY
- Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum
- (2008) Marick Laé et al. MODERN PATHOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started